2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2022-8-4-0-42892Genetics<strong>Knock-out of &alpha;-, &beta;-, and &gamma;-synuclein genes in mice leads to changes in the distribution of several lipids in the liver and blood plasma</strong><br /> &nbsp;<strong>Knock-out of &alpha;-, &beta;-, and &gamma;-synuclein genes in mice leads to changes in the distribution of several lipids in the liver and blood plasma</strong><br /> &nbsp;LysikovaEkaterina A.LysikovaEkaterina A.lysikova.ipac@gmail.comChaprovKirill D.ChaprovKirill D.chapkir@gmail.com20228400

Background:&nbsp;In addition to the role of synuclein proteins in synaptic transmission through binding with lipid membranes, the function of synucleins in reactions of the synthesis of lipids and fatty acids is also widely studied. Studying the disruption of lipid metabolism in Parkinson&rsquo;s disease caused by synuclein dysfunction is particularly interesting. The aim of the study:&nbsp;To determine the effect of the absence of synuclein family proteins on the total lipid content and the ratio of different lipid classes in the liver and blood plasma in transgenic mice. Materials and methods:&nbsp;Measurement of lipid classes of &alpha;&beta;&gamma;-synuclein triple knockout mice (N=6) and wild type controls (N=6) was performed by the HPLC on the silica gel plates. Results:&nbsp;A 1.4-fold (P&lt;0.05) increase in the percentage of total polar lipids was detected in the liver of knockout mice compared with the wild type, while the relative content of triglycerides decreased 1.2-fold (P&lt;0.05), respectively.&nbsp;At the same time plasma levels of the polar lipids and triacylglycerols were unaltered. The lack of synucleins causes changes in the levels of fatty acids in comparison to wild type animals: C16:0 levels increased 1.2-fold in the liver (P&lt;0.05) and 1.8-fold in plasma (P&lt;0.05), and C18:1n9 levels increased both 1.4-fold (P&lt;0.05) in plasma and 1.2-fold in the liver (P&lt;0.05).&nbsp;C20:4n6 levels decreased 1.5-fold (P&lt;0.05) in the liver of nonsynuclein mice. C18:2n6 levels decreased 7-fold in plasma (P&lt;0.05), but did not change in liver.&nbsp;Conclusion:&nbsp;Our data demonstrate that the absence of all three members of the synuclein family causes disruption of lipid metabolism and leads to altered synthesis of fatty acids and hepatic lipid accumulation.

Background:&nbsp;In addition to the role of synuclein proteins in synaptic transmission through binding with lipid membranes, the function of synucleins in reactions of the synthesis of lipids and fatty acids is also widely studied. Studying the disruption of lipid metabolism in Parkinson&rsquo;s disease caused by synuclein dysfunction is particularly interesting. The aim of the study:&nbsp;To determine the effect of the absence of synuclein family proteins on the total lipid content and the ratio of different lipid classes in the liver and blood plasma in transgenic mice. Materials and methods:&nbsp;Measurement of lipid classes of &alpha;&beta;&gamma;-synuclein triple knockout mice (N=6) and wild type controls (N=6) was performed by the HPLC on the silica gel plates. Results:&nbsp;A 1.4-fold (P&lt;0.05) increase in the percentage of total polar lipids was detected in the liver of knockout mice compared with the wild type, while the relative content of triglycerides decreased 1.2-fold (P&lt;0.05), respectively.&nbsp;At the same time plasma levels of the polar lipids and triacylglycerols were unaltered. The lack of synucleins causes changes in the levels of fatty acids in comparison to wild type animals: C16:0 levels increased 1.2-fold in the liver (P&lt;0.05) and 1.8-fold in plasma (P&lt;0.05), and C18:1n9 levels increased both 1.4-fold (P&lt;0.05) in plasma and 1.2-fold in the liver (P&lt;0.05).&nbsp;C20:4n6 levels decreased 1.5-fold (P&lt;0.05) in the liver of nonsynuclein mice. C18:2n6 levels decreased 7-fold in plasma (P&lt;0.05), but did not change in liver.&nbsp;Conclusion:&nbsp;Our data demonstrate that the absence of all three members of the synuclein family causes disruption of lipid metabolism and leads to altered synthesis of fatty acids and hepatic lipid accumulation.

synucleinstriple-knockout micepolar lipidsfatty acidssynucleinstriple-knockout micepolar lipidsfatty acidsСписок литературыShelkovnikova TA, Kulikova AA, Tsvetkov FO, et al. Proteinopathies &ndash; forms of neurodegenerative disorders with protein aggregation-based pathology. Molecular Biology. 2012;46(3):402-415. Russian. DOI: https://doi.org/10.1134/S0026893312020161Scott DA, Tabarean I, Tang Y, et al. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. Journal of Neuroscience. 2010;30(24):8083-8095. DOI: https://doi.org/10.1523/JNEUROSCI.1091-10.2010Burre J, Sharma M, Tsetsenis T, et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999):1663-1667. DOI: https://doi.org/10.1126/science.1195227Ninkina NN, Tarasova TV, Chaprov KD, et al. Synuclein deficiency decreases the efficiency of dopamine uptake by synaptic vesicles. Doklady Akademii nauk. 2019;486(1):114-117. Russian. DOI: https://doi.org/10.31857/S0869-56524861114-117Millership S, Ninkina N, Guschina IA, et al. Increased lipolysis and altered lipid homeostasis protect gamma-synuclein-null mutant mice from diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(51):20943-20948. DOI: https://doi.org/10.1073/pnas.1210022110Guschina I, Millership S, O&#39;Donnell V, et al. Lipid classes and fatty acid patterns are altered in the brain of gamma-synuclein null mutant mice. Lipids. 2011;46(2):121-130. DOI: https://doi.org/10.1007/s11745-010-3486-0Mori A, Imai Y, Hattori N. Lipids: Key Players That Modulate alpha-Synuclein Toxicity and Neurodegeneration in Parkinson&#39;s Disease. International Journal of Molecular Sciences. 2020;21(9):3301. DOI: https://doi.org/10.3390/ijms21093301Hayashi J, Carver JA. beta-Synuclein: An Enigmatic Protein with Diverse Functionality. Biomolecules. 2022;12(1):142. DOI: https://doi.org/10.3390/biom12010142Oort PJ, Knotts TA, Grino M, et al. Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity. Journal of Nutrition. 2008;138(5):841-848. DOI: https://doi.org/10.1093/jn/138.5.841Millership S, Ninkina N, Rochford JJ, et al. gamma-synuclein is a novel player in the control of body lipid metabolism. Adipocyte. 2013;2(4):276-280. DOI: https://doi.org/10.4161/adip.25162Ninkina N, Tarasova TV, Chaprov KD, et al. Alterations in the nigrostriatal system following conditional inactivation of alpha-synuclein in neurons of adult and aging mice. Neurobiology of Aging. 2020;91:76-87. DOI: https://doi.org/10.1016/j.neurobiolaging.2020.02.026Guschina IA, Ninkina N, Roman A, et al. Triple-Knockout, Synuclein-Free Mice Display Compromised Lipid Pattern. Molecules. 2021;26(11):3078. DOI: https://doi.org/10.3390/molecules26113078Fais M, Dore A, Galioto M, et al. Parkinson&#39;s Disease-Related Genes and Lipid Alteration. International Journal of Molecular Sciences. 2021;22(14):7630. DOI: https://doi.org/10.3390/ijms22147630Alecu I, Bennett SAL. Dysregulated Lipid Metabolism and Its Role in alpha-Synucleinopathy in Parkinson&#39;s Disease. Frontiers in Neuroscience. 2019;13:328. DOI: https://doi.org/10.3389/fnins.2019.00328Kim TE, Newman AJ, Imberdis T, et al. Excess membrane binding of monomeric alpha-, beta-, and gamma-synuclein is invariably associated with inclusion formation and toxicity. Human Molecular Genetics. 2021;30(23):2332-2346. DOI: https://doi.org/10.1093/hmg/ddab188Li P, Song C. Potential treatment of Parkinson&#39;s disease with omega-3 polyunsaturated fatty acids. Nutritional Neuroscience. 2022;25(1):180-191. DOI: https://doi.org/10.1080/1028415X.2020.1735143